Molecular Imaging: Page 92

New PET tracer targets iron in cancer

By AuntMinnie.com staff writers

For decades, researchers have known that cancer harbors an insatiable appetite for iron. Now they may have a PET tracer, called F-18 TRX, that targets iron on cancer cells, which could help in the development of therapies that exploit iron activity in tumors.

July 22, 2021

Point Biopharma, Isotopia sign clinical agreement for isotope

By AuntMinnie.com staff writers

Point Biopharma Global and Isotopia Molecular Imaging announced the companies have signed a clinical supply agreement for the medical radioisotope lutetium-177, a therapeutic isotope used in Point's pipeline of radiopharmaceutical assets.

July 22, 2021

ImaginAb signs new agreement with Boehringer Ingelheim

By AuntMinnie.com staff writers

ImaginAb has signed a new license agreement to supply its ImmunoPET radiotracer to Boehringer Ingelheim.

July 22, 2021

SNMMI supports new legislation to fix PET payment policy

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is throwing its support behind legislation introduced in the U.S. Congress that would change existing reimbursement policy toward PET radiopharmaceuticals.

July 21, 2021

Total-body PET/CT scanner in the works

By AuntMinnie.com staff writers

Quibim and other molecular imaging partners are collaborating on an $8.9 million project to build a total-body PET/CT scanner for simultaneous whole-body imaging.

July 20, 2021

PET developer Positron retains strategic advisor

By AuntMinnie.com staff writers

PET developer Positron has retained a strategic advisor to help the company refine its strategy in the nuclear medicine and molecular imaging market.

July 15, 2021

Micro-PET/CT shows long-term Ritalin use safe in ADHD

By Will Morton

Adults who started taking methylphenidate, also known as Ritalin, when they were children for attention deficit hyperactivity disorder (ADHD) may be able to lay aside concerns over whether the drug has neurotoxic effects, according to authors of an animal study published July 12 in Neurotoxicology and Teratology.

July 14, 2021

CMS to analyze coverage of monoclonal antibody Alzheimer's drug

By AuntMinnie.com staff writers

The U.S. Centers for Medicare and Medicaid Services (CMS) will conduct a national coverage determination analysis of beta amyloid-directed monoclonal antibody treatment for Alzheimer's disease, including the new drug aducanumab.

July 13, 2021

International Isotopes snaps up remaining RadQual shares

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes has purchased all remaining shares in its subsidiary RadQual, completing a transaction that began in 2017.

July 11, 2021

FDG-PET identifies biomarkers in dementia with Lewy bodies

By Will Morton

FDG-PET can identify whether mild cognitive impairment is associated with dementia with Lewy bodies or with Alzheimer's disease, two neurodegenerative conditions that can be indistinguishable in later stages, according to a study published July 4 in NeuroImage: Clinical.

July 7, 2021

PET brain scans find links to PTSD severity in 9/11 responders

By Will Morton

PET imaging has revealed a link between unusual brain activity and the severity of post-traumatic stress disorder (PTSD) in 9/11 responders due to their experiences at the World Trade Center in New York in 2001, according to a study published June 30 in Brain, Behavior, and Immunity -- Health.

July 1, 2021

Ga-68 PSMA-11 improves outcomes in prostate cancer patients

By Will Morton

PET with a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA)-11 radiotracer should be the standard imaging modality for guiding stereotactic ablative radiotherapy in oligometastatic prostate cancer patients, according to a June 29 study in Clinical and Translational Radiation Oncology.

July 1, 2021

Previous Page

Page 92 of 614

Next Page